INTRODUCTION AND AIMS:
Optimal phosphate control is still an unmet need in chronic kidney disease (CKD). High serum phosphate increases calcification burden and is associated with mortality and cardiovascular disease in CKD. METHODS: We therefore studied nicotinamide and magnesium carbonate (MC) as phosphate modulators/-binder in a mouse model of CKD and in in vitro cell culture of human vascular smooth muscle cells and murine Gli1 þ progenitor cells. DBA/2 mice underwent 5/6 nephrectomy and were treated for 7 weeks with nicotinamide, magnesium carbonate or a combination of both. In vitro, calcifying cells were treated in the same way. RESULTS: Nephrectomy alone increased s-urea, s-creatinine, s-FGF23, fractional phosphate excretion and decreased GFR, as expected. MC treatment alone lead to decreased soft tissue calcification in this mouse model, while it induced upregulation of the intestinal phosphate transporter proteins NaPi-IIb and Pit-1. Monotherapy with nicotinamide alone also increased calcium content of various tissues. However, our data indicated that the combined therapy of nicotinamide with MC might be beneficial, as nicotinamide treatment was able to ameliorate the MC induced increased expression of intestinal phosphate transporter proteins and thus reduced calcification burden. All treatments reduced s-FGF23. In vitro, increased alkaline phosphatase activity, as readout of cell-calcification intensity, showed similar trends compared to in vivo calcium accumulation. Interestingly, in Gli1 þ progenitors, increased alkaline phosphatase activity was decreased by 2PY, the main metabolite of nicotinamide, during calcification. CONCLUSIONS: Our data indicate that magnesium carbonate reduces calcification in a DBA/2 mouse CKD model but upregulates intestinal phosphate transporters. This upregulation can be blocked by add-on therapy with nicotinamide. Wellnesscenter, Nagoya Kyoritsu Hospital, Nagoya, Aichi, Japan and 3 Rehabilitation, Seirei Christopher University, Hamamatsu, Shizuoka, Japan INTRODUCTION AND AIMS: For dialysis patients, muscle strength and physical performance decrease with aging and long-term continuation of dialysis treatment, and it becomes easy to fall into the condition requiring long term care after the frailty. Frailty is reversible and it can be dealt with by appropriate rehabilitation, and the evidence of exercise for dialysis patients has been reported in some papers recently. To perform a dialysis regularly, walking on their own feet is important not only to enhance the quality of life of the patient himself but also to reduce the burden of caregivers and medical institutions staff. In addition, it is important to prevent the decline in walking ability, as it is reported that the amount of physical activity by walking is related to life expectancy. However, once the ability to walk is lost, it is known that acquiring independent walking ability again require a long period and is often difficult. Therefore, the aim of this study is to clarify the factors related to loss of walking ability of dialysis patients. METHODS: Of the 179 outpatients undergoing maintenance hemodialysis, 93 patients who were evaluated in both September 2013 (first time) and September 2017 (four years later) were subjects. In patient attributes, age, dialysis period, comorbidity, biochemical data, geriatric nutritional risk index (GNRI) as nutritional status were examined from the medical records. For evaluating physical function, fat free mass, muscle strength, short physical performance battery (SPPB), walking speed were measured by physical therapist. We investigated the factors involved in the loss of walking ability by multiple logistic analysis and ROC analysis with the loss of walking ability as dependent variable and patient attribute and physical function as independent variables. RESULTS: Seven patients (8%) had lost their walking ability in four years. Factors involved in the loss of walking ability were the first SPPB scores (odds ratio, 0.786; 95% CI, 0.628 -0.982; p ¼ 0.03). In the case the SPPB cutoff value was 8 or less, the odds ratio to loss of walking ability was 10.578 (95% CI, 1.382 -80.967; p ¼ 0.02), the sensitivity was 0.714, the specificity was 0.791, and the area under the curve was 0.786 (p ¼ 0.01). CONCLUSIONS: It was suggested that in the situation of the score of SPPB that is an index of simply physical performance falls below the 8 points, there is a high risk of losing walking ability in several years later. We concluded that comprehensive rehabilitation including exercise therapy and fall prevention is preferentially necessary in these patients. 
Physical inactivity may be associated with muscular skeletal pain and reduced physical function in patients undergoing dialysis. The aim of this study was 1) to compare physical activity, low back pain frequency and physical function in patients undergoing dialysis with age and gender matched data from the general population, and 2) to assess the association between physical activity, low back pain frequency and physical function in patients undergoing dialysis. METHODS: Adult patients undergoing dialysis in the Capital Region, Denmark, were recruited to the cross sectional study. Inclusion criteria were dialysis treatment for minimum three months and ability to walk 50 meters. Exclusion criteria were hospital admission within the past month, dementia and inability to speak Danish. Clinical data were collected from electronic databases. Self-reported physical activity level categorized as active and inactive, pain, and socioeconomic position assessed as educational level were reported in a questionnaire. Data for the general population were reported by The Danish Health and Morbidity Survey and they were matched to the patients using the patients' age, gender and national region as weights. Physical function was tested using the 30-seconds Chair Stand Test. Data analyses included multinomial regression analyses adjusted for age, gender, dialysis modality, socioeconomic position, body mass index, and haemoglobin and albumin levels. RESULTS: 343 patients participated in the study (haemodialysis/peritoneal dialysis n¼281/62; male/female n¼204/139; age (mean 6 SD) 63 6 14 years). Being physically active was reported by 63.2% of the patients versus 80.1% in the general population (p<0.01). Low back pain was reported by 53.5% versus 52.8% in the general population (p>0.05). The patients performed 10.4 6 5.7 rises in the 30-seconds Chair Stand Test versus 14.4 6 1.4 rises in the general population (p<0.001). The association between physical activity (dependent variable) and low back pain (independent variable) was not significant in a logistic regression analysis, in which female gender and increasing body mass index were associated with low back pain (OR 2.3 (1.4-4.0 95% CI) and (OR 1.07 (1.02-1.12), respectively). The association between physical activity (dependent variable) and physical function (independent variable) was not significant in a linear regression analysis, in which lower age and a higher p-albumin level were associated with good physical function (b -1.4 (-1.8-0.9) and (b 0.14 (0.02-0.26), respectively). CONCLUSIONS: Even though physical activity may have a positive impact on pain related to the musculoskeletal system, physical activity was not associated with the frequency of low back pain in the mobile patients undergoing dialysis in the present study. The increasing prevalence of obesity may however induce low back pain, which was associated with increasing body mass index. Surprisingly, physical activity was neither associated with the patients' reduced physical function, whereas an increased nutritional status determined by p-albumin was associated with physical function. The relatively reduced percentage of physically active patients may have other negative implications, among them impaired metabolism. 
METHODS:
The total number of participants was 2,737 from 27 dialysis centers. Among these, 1,615 dialysis patients were recruited into our study. We evaluated disability by using 4 questions on activities of daily living (ADLs) concerning whether help was needed for feeding, dressing/undressing, getting in/out of bed, or taking a bath/ shower. We divided patients into 3 groups: Non-D (non-disabled, none of the 4 ADL domains required help), Mild-D (mildly disabled, 1 ADL domain required some or full help), or MS-D (moderate to severely disabled, 2 or more ADL domains required some or full help). We evaluated falls, frailty, exhaustion, and health-related quality of life (HRQoL). All mortality and hospitalization data were retrieved from medical records. 
